Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.118.253708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Vemurafenib in the Treatment of Brain Metastases From Melanoma

Onkologiya. Zhurnal imeni P.A.Gertsena
2014English

Melanoma Brain Metastases: An Unmet Challenge in the Era of Active Therapy

Current Oncology Reports
Oncology
2013English

Treatment of Brain Metastases

Revista da Associacao Medica Brasileira
Medicine
2016English

Whole Brain Radiotherapy (WBRT) After Local Treatment of Brain Metastases in Melanoma Patients: Statistical Analysis Plan

Trials
MedicinePharmacology
2019English

Clinical Management of Multiple Melanoma Brain Metastases

JAMA Oncology
Cancer ResearchOncology
2015English

Molecular Insights Into Melanoma Brain Metastases

Cancer
Cancer ResearchOncology
2017English

Challenges in the Delivery of Therapies to Melanoma Brain Metastases

Current Pharmacology Reports
BiochemistryDrug DiscoveryGeneticsPharmacology
2016English

Pembrolizumab Produces Durable Responses in Melanoma Brain Metastases

Cancer Discovery
Oncology
2018English

Clinical Trials in Melanoma Patients With Brain Metastases

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy